Aviva PLC Meridian Bioscience Inc Transaction History

Aviva PLC

  • $36.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$31.15 - $33.39 $312,029 - $334,467
10,017 New
10,017 $333,000
Q2 2022

Aug 04, 2022
SELL
$23.75 - $31.69 $328,177 - $437,892
-13,818 Reduced 16.0%
72,567 $2.21 Million
Q1 2022

May 13, 2022
BUY
$19.97 - $26.94 $1.73 Million - $2.33 Million
86,385 New
86,385 $2.24 Million

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email